Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Esra A. Akbay(Southwestern Medical Center), Mei Zheng
Cited by 11
Related Papers
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
|Journal for ImmunoTherapy of Cancer|2019|152
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
|Genes & Development|2014|86